BCAR1 CLIA Kit
-
- Target See all BCAR1 CLIA Kits
- BCAR1 (Breast Cancer Anti-Estrogen Resistance 1 (BCAR1))
-
Reactivity
- Human
- Detection Method
- Chemiluminescent
- Method Type
- Sandwich ELISA
- Detection Range
- 78.12 pg/mL - 5000 pg/mL
- Minimum Detection Limit
- 78.12 pg/mL
- Application
- ELISA
- Purpose
- Human Breast Cancer Anti-Estrogen Resistance 1 (BCAR1) CLIA Kit is a Sandwich CLIA Kit for use with Serum, plasma, tissue homogenates and other biological fluids.
- Sample Type
- Plasma, Serum, Tissue Homogenate
- Analytical Method
- Quantitative
- Sensitivity
- < 27 pg/mL
- Top Product
- Discover our top product BCAR1 ELISA Kit
-
Breast Cancer Anti-Estrogen Resistance 1 (BCAR1) ELISA Kit
BCAR1 Reactivity: Human Colorimetric Sandwich ELISA 78.12 pg/mL - 5000 pg/mL Plasma, Serum, Tissue Homogenate
Breast Cancer Anti-Estrogen Resistance 1 (BCAR1) ELISA KitBCAR1 Reactivity: Human Colorimetric Sandwich ELISA 0.156 ng/mL - 10 ng/mL Plasma, Serum, Tissue Homogenate
-
- Application Notes
-
Stability: The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5 % within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout.
Recommended dilutions: Optimal dilutions/concentrations should be determined by the end user.
Standard Form: Lyophilized
- Plate
- Pre-coated
- Restrictions
- For Research Use only
-
- Storage
- 4 °C/-20 °C
- Storage Comment
- Upon receipt, store the kit according to the storage instruction in the kit's manual.
- Expiry Date
- 6 months
-
- Target See all BCAR1 CLIA Kits
- BCAR1 (Breast Cancer Anti-Estrogen Resistance 1 (BCAR1))
- Abstract
- BCAR1 Products
- Pathways
- EGFR Signaling Pathway, Neurotrophin Signaling Pathway, CXCR4-mediated Signaling Events, Platelet-derived growth Factor Receptor Signaling
-
